• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Celanese Corporation

    12/6/24 12:11:25 PM ET
    $CE
    Major Chemicals
    Industrials
    Get the next $CE alert in real time by email
    SC 13G/A 1 d851276dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (AMENDMENT NO. 15)*

     

     

    CELANESE CORPORATION

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    150870103

    (CUSIP Number)

    November 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☒

    Rule 13d-1(b)

    ☐

    Rule 13d-1(c)

    ☐

    Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

    PAGE 1 OF 5 PAGES


     

    CUSIP NO. 150870103    13G    PAGE 2 OF 5 PAGES

     

     1   

     NAME OF REPORTING PERSON

     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     

     Dodge & Cox            94-1441976

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     N/A

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     California - U.S.A.

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     10,332,523

       6  

     SHARED VOTING POWER

     

     0

       7  

     SOLE DISPOSITIVE POWER

     

     10,935,953

       8  

     SHARED DISPOSITIVE POWER

     

     0

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     10,935,953

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     N/A

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     10.0%

    12  

     TYPE OF REPORTING PERSON*

     

     IA

     

    PAGE 2 OF 5 PAGES


    Item 1(a)    Name of Issuer:
       CELANESE CORPORATION
    Item 1(b)    Address of Issuer’s Principal Executive Offices:
       222 W. Las Colinas Blvd.
       Suite 900N
       Irving, Texas 75039-5421
    Item 2(a)    Name of Person Filing:
       Dodge & Cox
    Item 2(b)    Address of the Principal Office or, if none, Residence:
       555 California Street, 40th Floor
       San Francisco, CA 94104
    Item 2(c)    Citizenship:
       California—U.S.A.
    Item 2(d)    Title of Class of Securities:
       Common Stock
    Item 2(e)    CUSIP Number:
       150870103
    Item 3    If the Statement is being filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:
      

    (e)   ☒ Investment Advisor registered under section 203 of the Investment Advisors Act of 1940

    Item 4    Ownership:
      

    (a)   Amount Beneficially Owned:

      

    10,935,953

      

    (b)   Percent of Class:

      

    10.0%

     

    PAGE 3 OF 5 PAGES


      

    (c)   Number of shares as to which such person has:

      

    (i) sole power to vote or direct the vote: 10,332,523

      

    (ii)  shared power to vote or direct the vote: 0

      

    (iii)  sole power to dispose or to direct the disposition of: 10,935,953

      

    (iv) shared power to dispose or to direct the disposition of: 0

    Item 5    Ownership of Five Percent or Less of a Class:
       Not applicable.
    Item 6    Ownership of More than Five Percent on Behalf of Another Person:
       The clients of Dodge & Cox, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or power to direct the receipt of dividends from, and the proceeds from the sale of, CELANESE CORPORATION.
       Dodge & Cox Stock Fund, an investment company registered under the Investment Company Act of 1940, has an interest of 7,499,898, or 6.9%, of the class of securities reported herein.
    Item 7    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:
       Not applicable.
    Item 8    Identification and Classification of Members of the Group:
       Not applicable.
    Item 9    Notice of Dissolution of a Group:
       Not applicable.
    Item 10    Certification:
       By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

     

    PAGE 4 OF 5 PAGES


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: December 6, 2024

     

    DODGE & COX
    By:  

    /S/ Katherine M. Primas

    Name:   Katherine M. Primas
    Title:   Chief Compliance Officer

     

    PAGE 5 OF 5 PAGES

    Get the next $CE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CE

    DatePrice TargetRatingAnalyst
    6/16/2025$66.00Equal Weight → Overweight
    Wells Fargo
    5/20/2025$55.00Underperform → Market Perform
    BMO Capital Markets
    3/21/2025$76.00Sector Weight → Overweight
    KeyBanc Capital Markets
    3/17/2025$70.00Neutral → Overweight
    Alembic Global Advisors
    3/6/2025$66.00Sell → Hold
    Vertical Research
    2/20/2025$84.00 → $56.00Outperform → Sector Perform
    RBC Capital Mkts
    1/14/2025$95.00 → $88.00Underperform → Buy
    BofA Securities
    11/11/2024$161.00 → $97.00Buy → Neutral
    UBS
    More analyst ratings